Regulation of cholesterol homeostasis

Molecular and Cellular Endocrinology

Volumn 368, Issue 1-2, 2013, Pages 1-16

  Van Der Wulp, Mariëtte Y M ^a,b   Verkade, Henkjan J ^a,b   Groen, Albert K ^a,b  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Cholesterol absorption; Cholesterol excretion; Cholesterol synthesis; Reverse cholesterol transport; Transintestinal cholesterol excretion

Indexed keywords

ANACETRAPIB; CARRIER PROTEIN; CHOLESTEROL; CHOLESTEROL-ESTER TRANSPORT PROTEIN; DALCETRAPIB; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER X RECEPTOR AGONIST; MEVINOLIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PHYTOSTEROL; PITAVASTATIN; PRAVASTATIN; SIMVASTATIN; STANOZOLOL; UNCLASSIFIED DRUG;

ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; DIET SUPPLEMENTATION; DRUG DOSE COMPARISON; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; FAT INTAKE; FECES; HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; IN VIVO STUDY; MYALGIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPEATED DRUG DOSE; REVIEW; RHABDOMYOLYSIS; SINGLE DRUG DOSE; TREATMENT RESPONSE;

ANIMALS; ANTICHOLESTEREMIC AGENTS; BIOLOGICAL TRANSPORT; CHOLESTEROL; CIRCADIAN RHYTHM; DIET; HOMEOSTASIS; HUMANS; HYPERCHOLESTEROLEMIA; INTESTINAL ABSORPTION; ORGAN SPECIFICITY;

EID: 84875250692     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.06.007     Document Type: Review

References (185)

1. AbuMweis S.S., Vanstone C.A., Lichtenstein A.H., Jones P.J. Plant sterol consumption frequency affects plasma lipid levels and cholesterol kinetics in humans. Eur. J. Clin. Nutr. 2009, 63:747-755.
2. Acimovic J., Fink M., Pompon D., Bjorkhem I., Hirayama J., Sassone-Corsi P., Golicnik M., Rozman D. CREM modulates the circadian expression of CYP51, HMGCR and cholesterogenesis in the liver. Biochem. Biophys. Res. Commun. 2008, 376:206-210.
3. Acimovic J., Kosir R., Kastelec D., Perse M., Majdic G., Rozman D., Kosmelj K., Golicnik M. Circadian rhythm of cholesterol synthesis in mouse liver: a statistical analysis of the post-squalene metabolites in wild-type and Crem-knock-out mice. Biochem. Biophys. Res. Commun. 2011, 408:635-641.
4. Altmann S.W., Davis H.R., Yao X., Laverty M., Compton D.S., Zhu L.J., Crona J.H., Caplen M.A., Hoos L.M., Tetzloff G., Priestley T., Burnett D.A., Strader C.D., Graziano M.P. The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption. Biochim. Biophys. Acta 2002, 1580:77-93.
5. Altmann S.W., Davis H.R., Zhu L.J., Yao X., Hoos L.M., Tetzloff G., Iyer S.P., Maguire M., Golovko A., Zeng M., Wang L., Murgolo N., Graziano M.P. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 2004, 303:1201-1204.
6. Bass J., Takahashi J.S. Circadian integration of metabolism and energetics. Science 2010, 330:1349-1354.
7. Bays H.E., Neff D., Tomassini J.E., Tershakovec A.M. Ezetimibe: cholesterol lowering and beyond. Expert Rev. Cardiovasc. Ther. 2008, 6:447-470.
8. Bays H.E., Davidson M.H., Massaad R., Flaim D., Lowe R.S., Tershakovec A.M., Jones-Burton C. Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study). Am. J. Cardiol. 2011, 108:523-530.
9. Berge K.E., Tian H., Graf G.A., Yu L., Grishin N.V., Schultz J., Kwiterovich P., Shan B., Barnes R., Hobbs H.H. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000, 290:1771-1775.
10. Bilheimer D.W., Stone N.J., Grundy S.M. Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo. J. Clin. Invest. 1979, 64:524-533.
11. Bilheimer D.W., Goldstein J.L., Grundy S.M., Starzl T.E., Brown M.S. Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N. Engl. J. Med. 1984, 311:1658-1664.
12. Bloch K. The biological synthesis of cholesterol. Science 1965, 150:19-28.
13. Bosner M.S., Ostlund R.E., Osofisan O., Grosklos J., Fritschle C., Lange L.G. Assessment of percent cholesterol absorption in humans with stable isotopes. J. Lipid Res. 1993, 34:1047-1053.
14. Brown J.M., Bell T.A., Alger H.M., Sawyer J.K., Smith T.L., Kelley K., Shah R., Wilson M.D., Davis M.A., Lee R.G., Graham M.J., Crooke R.M., Rudel L.L. Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss. J. Biol. Chem. 2008, 283:10522-10534.
15. Brown A.W., Hang J., Dussault P.H., Carr T.P. Phytosterol ester constituents affect micellar cholesterol solubility in model bile. Lipids 2010, 45:855-862.
16. Brufau G., Groen A.K., Kuipers F. Reverse cholesterol transport revisited: contribution of biliary versus intestinal cholesterol excretion. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1726-1733.
17. Brufau G., Kuipers F., Lin Y., Trautwein E.A., Groen A.K. A reappraisal of the mechanism by which plant sterols promote neutral sterol loss in mice. PLoS ONE 2011, 6:e21576.
18. Brunham L.R., Kruit J.K., Iqbal J., Fievet C., Timmins J.M., Pape T.D., Coburn B.A., Bissada N., Staels B., Groen A.K., Hussain M.M., Parks J.S., Kuipers F., Hayden M.R. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J. Clin. Invest. 2006, 116:1052-1062.
19. Buhman K.K., Accad M., Novak S., Choi R.S., Wong J.S., Hamilton R.L., Turley S., Farese R.V. Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat. Med. 2000, 6:1341-1347.
20. Calpe-Berdiel L., Escola-Gil J.C., Blanco-Vaca F. Phytosterol-mediated inhibition of intestinal cholesterol absorption is independent of ATP-binding cassette transporter A1. Br. J. Nutr. 2006, 95:618-622.
21. Calpe-Berdiel L., Escola-Gil J.C., Blanco-Vaca F. Are LXR-regulated genes a major molecular target of plant sterols/stanols?. Atherosclerosis 2007, 195:210-211.
22. Cariou B., Le May C., Costet P. Clinical aspects of PCSK9. Atherosclerosis 2011, 216:258-265.
23. Cheng S.H., Stanley M.M. Secretion of cholesterol by intestinal mucosa in patients with complete common bile duct obstruction. Proc. Soc. Exp. Biol. Med. 1959, 101:223-225.
24. Choi M.K., Shin H.J., Choi Y.L., Deng J.W., Shin J.G., Song I.S. Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors. Xenobiotica 2011, 41:24-34.
25. Cohn J.S., Kamili A., Wat E., Chung R.W., Tandy S. Reduction in intestinal cholesterol absorption by various food components: mechanisms and implications. Atheroscler. Suppl. 2010, 11:45-48.
26. Corsini A., Ceska R. Drug-drug interactions with statins: will pitavastatin overcome the statins' Achilles' heel?. Curr. Med. Res. Opin. 2011, 27:1551-1562.
27. Cruz M.L., Wong W.W., Mimouni F., Hachey D.L., Setchell K.D., Klein P.D., Tsang R.C. Effects of infant nutrition on cholesterol synthesis rates. Pediatr. Res. 1994, 35:135-140.
28. Daumerie C.M., Woollett L.A., Dietschy J.M. Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools. Proc. Natl. Acad. Sci. USA 1992, 89:10797-10801.
29. Davis H.R., Altmann S.W. Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter. Biochim. Biophys. Acta 2009, 1791:679-683.
30. Davis H.R., Zhu L.J., Hoos L.M., Tetzloff G., Maguire M., Liu J., Yao X., Iyer S.P., Lam M.H., Lund E.G., Detmers P.A., Graziano M.P., Altmann S.W. Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J. Biol. Chem. 2004, 279:33586-33592.
31. de Haan W., de Vries-van der Weij J., van der Hoorn J.W., Gautier T., van der Hoogt C.C., Westerterp M., Romijn J.A., Jukema J.W., Havekes L.M., Princen H.M., Rensen P.C. Torcetrapib does not reduce atherosclerosis beyond atorvastatin and induces more proinflammatory lesions than atorvastatin. Circulation 2008, 117:2515-2522.
32. de vogel-van den Bosch H.M., deWit N.J., Hooiveld G.J., Vermeulen H., van der Veen J.N., Houten S.M., Kuipers F., Muller M., van der Meer R. A cholesterol-free, high-fat diet suppresses gene expression of cholesterol transporters in murine small intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:G1171-G1180.
33. DenBesten L., Reyna R.H., Connor W.E., Stegink L.D. The different effects on the serum lipids and fecal steroids of high carbohydrate diets given orally or intravenously. J. Clin. Invest. 1973, 52:1384-1393.
34. Di Buono M., Jones P.J., Beaumier L., Wykes L.J. Comparison of deuterium incorporation and mass isotopomer distribution analysis for measurement of human cholesterol biosynthesis. J. Lipid Res. 2000, 41:1516-1523.
35. Dietschy J.M. Central nervous system: cholesterol turnover, brain development and neurodegeneration. Biol. Chem. 2009, 390:287-293.
36. Dietschy J.M., Spady D.K. Measurement of rates of cholesterol synthesis using tritiated water. J. Lipid Res. 1984, 25:1469-1476.
37. Dietschy J.M., Turley S.D., Spady D.K. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J. Lipid Res. 1993, 34:1637-1659.
38. Dikkers A., Tietge U.J. Biliary cholesterol secretion: more than a simple ABC. World J. Gastroenterol. 2010, 16:5936-5945.
39. Drobnik W., Lindenthal B., Lieser B., Ritter M., Christiansen Weber T., Liebisch G., Giesa U., Igel M., Borsukova H., Buchler C., Fung-Leung W.P., Von Bergmann K., Schmitz G. ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism. Gastroenterology 2001, 120:1203-1211.
40. Endo A., Tsujita Y., Kuroda M., Tanzawa K. Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Eur. J. Biochem. 1977, 77:31-36.
41. Faix D., Neese R., Kletke C., Wolden S., Cesar D., Coutlangus M., Shackleton C.H., Hellerstein M.K. Quantification of menstrual and diurnal periodicities in rates of cholesterol and fat synthesis in humans. J. Lipid Res. 1993, 34:2063-2075.
42. Fujino H., Saito T., Ogawa S., Kojima J. Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase. J. Pharm. Pharmacol. 2005, 57:1305-1311.
43. Ge L., Wang J., Qi W., Miao H.H., Cao J., Qu Y.X., Li B.L., Song B.L. The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1. Cell Metab. 2008, 7:508-519.
44. Gill S., Stevenson J., Kristiana I., Brown A.J. Cholesterol-dependent degradation of squalene monooxygenase, a control point in cholesterol synthesis beyond HMG-CoA reductase. Cell Metab. 2011, 13:260-273.
45. Glomset J.A. Physiological role of lecithin-cholesterol acyltransferase. Am. J. Clin. Nutr. 1970, 23:1129-1136.
46. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature 1990, 343:425-430.
47. Goncalves A., Gleize B., Bott R., Nowicki M., Amiot M.J., Lairon D., Borel P., Reboul E. Phytosterols can impair vitamin D intestinal absorption in vitro and in mice. Mol. Nutr. Food Res. 2011, 55(Suppl 2):S303-11.
48. Goodman D.S., Smith F.R., Seplowitz A.H., Ramakrishnan R., Dell R.B. Prediction of the parameters of whole body cholesterol metabolism in humans. J. Lipid Res. 1980, 21:699-713.
49. Gordon D.A., Jamil H. Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly. Biochim. Biophys. Acta 2000, 1486:72-83.
50. Gremaud G., Dalan E., Piguet C., Baumgartner M., Ballabeni P., Decarli B., Leser M.E., Berger A., Fay L.B. Effects of non-esterified stanols in a liquid emulsion on cholesterol absorption and synthesis in hypercholesterolemic men. Eur. J. Nutr. 2002, 41:54-60.
51. Greupink R., Dillen L., Monshouwer M., Huisman M.T., Russel F.G. Interaction of fluvastatin with the liver-specific Na(+)-dependent taurocholate cotransporting polypeptide (NTCP). Eur. J. Pharm. Sci. 2011, 44:487-496.
52. Groen A.K., Bloks V.W., Bandsma R.H., Ottenhoff R., Chimini G., Kuipers F. Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL. J. Clin. Invest. 2001, 108:843-850.
53. Grundy S.M., Metzger A.L. A physiological method for estimation of hepatic secretion of biliary lipids in man. Gastroenterology 1972, 62:1200-1217.
54. Grundy S.M., Mok H.Y. Determination of cholesterol absorption in man by intestinal perfusion. J. Lipid Res. 1977, 18:263-271.
55. Guardamagna O., Abello F., Baracco V., Federici G., Bertucci P., Mozzi A., Mannucci L., Gnasso A., Cortese C. Primary hyperlipidemias in children: effect of plant sterol supplementation on plasma lipids and markers of cholesterol synthesis and absorption. Acta Diabetol. 2011, 48:127-133.
56. Gylling H., Laaksonen D.E., Atalay M., Hallikainen M., Niskanen L., Miettinen T.A. Markers of absorption and synthesis of cholesterol in men with type 1 diabetes. Diabetes Metab. Res. Rev. 2007, 23:372-377.
57. Hawes B.E., O'neill K.A., Yao X., Crona J.H., Davis H.R., Graziano M.P., Altmann S.W. In vivo responsiveness to ezetimibe correlates with niemann-pick C1 like-1 (NPC1L1) binding affinity: Comparison of multiple species NPC1L1 orthologs. Mol. Pharmacol. 2007, 71:19-29.
58. Heinemann T., Axtmann G., von Bergmann K. Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur. J. Clin. Invest. 1993, 23:827-831.
59. Hellerstein M.K., Neese R.A. Mass isotopomer distribution analysis at eight years: theoretical, analytic, and experimental considerations. Am. J. Physiol. 1999, 276:E1146-70.
60. Ho R.H., Tirona R.G., Leake B.F., Glaeser H., Lee W., Lemke C.J., Wang Y., Kim R.B. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology 2006, 130:1793-1806.
61. Horton J.D., Goldstein J.L., Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 2002, 109:1125-1131.
62. Horvat S., McWhir J., Rozman D. Defects in cholesterol synthesis genes in mouse and in humans: lessons for drug development and safer treatments. Drug Metab. Rev. 2011, 43:69-90.
63. Huang J.C., Lee T.Y., Liou M.J., Lin C.M., Pei D., Chen Z.C., Liu R.T., Kwok C.F. Begin with the real-world patients of non-goal-achieved hypercholesterolemia in taiwan through the ezetimibe/simvastatin tablet - The BRAVO Study. Curr. Med. Res. Opin. 2011, 27:1645-1651.
64. Hui D.Y., Howles P.N. Carboxyl ester lipase: structure-function relationship and physiological role in lipoprotein metabolism and atherosclerosis. J. Lipid Res. 2002, 43:2017-2030.
65. Ikeda I., Matsuoka R., Hamada T., Mitsui K., Imabayashi S., Uchino A., Sato M., Kuwano E., Itamura T., Yamada K., Tanaka K., Imaizumi K. Cholesterol esterase accelerates intestinal cholesterol absorption. Biochim. Biophys. Acta 2002, 1571:34-44.
66. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 1993, 92:883-893.
67. Jakulj L., Trip M.D., Sudhop T., von Bergmann K., Kastelein J.J., Vissers M.N. Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels. J. Lipid Res. 2005, 46:2692-2698.
68. Jakulj L., Vissers M.N., Groen A.K., Hutten B.A., Lutjohann D., Veltri E.P., Kastelein J.J. Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial. J. Lipid Res. 2010, 51:755-762.
69. Jakulj L., Vissers M.N., van Roomen C.P., van der Veen J.N., Vrins C.L., Kunne C., Stellaard F., Kastelein J.J., Groen A.K. Ezetimibe stimulates faecal neutral sterol excretion depending on abcg8 function in mice. FEBS Lett. 2010, 584:3625-3628.
70. Jolley C.D., Dietschy J.M., Turley S.D. Genetic differences in cholesterol absorption in 129/Sv and C57BL/6 mice: effect on cholesterol responsiveness. Am. J. Physiol. 1999, 276:G1117-G1124.
71. Jones P.J. Regulation of cholesterol biosynthesis by diet in humans. Am. J. Clin. Nutr. 1997, 66:438-446.
72. Jones P.J., Schoeller D.A. Evidence for diurnal periodicity in human cholesterol synthesis. J. Lipid Res. 1990, 31:667-673.
73. Jones P.J., Lichtenstein A.H., Schaefer E.J. Interaction of dietary fat saturation and cholesterol level on cholesterol synthesis measured using deuterium incorporation. J. Lipid Res. 1994, 35:1093-1101.
74. Jones P.J., Ausman L.M., Croll D.H., Feng J.Y., Schaefer E.A., Lichtenstein A.H. Validation of deuterium incorporation against sterol balance for measurement of human cholesterol biosynthesis. J. Lipid Res. 1998, 39:1111-1117.
75. Kallien G., Lange K., Stange E.F., Scheibner J. The pravastatin-induced decrease of biliary cholesterol secretion is not directly related to an inhibition of cholesterol synthesis in humans. Hepatology 1999, 30:14-20.
76. Kannel W.B., Castelli W.P., Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann. Intern. Med. 1979, 90:85-91.
77. Kirby R.J., Zheng S., Tso P., Howles P.N., Hui D.Y. Bile salt-stimulated carboxyl ester lipase influences lipoprotein assembly and secretion in intestine: a process mediated via ceramide hydrolysis. J. Biol. Chem. 2002, 277:4104-4109.
78. Klass D.M., Buhrmann K., Sauter G., Del Puppo M., Scheibner J., Fuchs M., Stange E.F. Biliary lipids, cholesterol and bile synthesis: different adaptive mechanisms to dietary cholesterol in lean and obese subjects. Aliment. Pharmacol. Ther. 2006, 23:895-905.
79. Knopp, R.H., Gitter, H., Truitt, T., Bays, H., Manion, C.V., Lipka, L.J., LeBeaut, A.P., Suresh, R., Yang, B., Veltri, E.P., Ezetimibe Study Group Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. Eur. Heart J. 2003, 24:729-741.
80. Kramer W., Girbig F., Corsiero D., Pfenninger A., Frick W., Jahne G., Rhein M., Wendler W., Lottspeich F., Hochleitner E.O., Orso E., Schmitz G. Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane. J. Biol. Chem. 2005, 280:1306-1320.
81. Krauss R.M., Mangravite L.M., Smith J.D., Medina M.W., Wang D., Guo X., Rieder M.J., Simon J.A., Hulley S.B., Waters D., Saad M., Williams P.T., Taylor K.D., Yang H., Nickerson D.A., Rotter J.I. Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment. Circulation 2008, 117:1537-1544.
82. Kreuzer J. Phytosterols and phytostanols: is it time to rethink that supplemented margarine?. Cardiovasc. Res. 2011, 90:397-398.
83. Kritchevsky D., Tepper S.A. The free and ester sterol content of various foodstuffs. J. Nutr. 1961, 74:441-444.
84. Kruit J.K., Plosch T., Havinga R., Boverhof R., Groot P.H., Groen A.K., Kuipers F. Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice. Gastroenterology 2005, 128:147-156.
85. Kruit J.K., Groen A.K., van Berkel T.J., Kuipers F. Emerging roles of the intestine in control of cholesterol metabolism. World J. Gastroenterol. 2006, 12:6429-6439.
86. Lakoski S.G., Xu F., Vega G.L., Grundy S.M., Chandalia M., Lam C., Lowe R.S., Stepanavage M.E., Musliner T.A., Cohen J.C., Hobbs H.H. Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin. J. Clin. Endocrinol. Metab. 2010, 95:800-809.
87. Landray M., Baigent C., Leaper C., Adu D., Altmann P., Armitage J., Ball S., Baxter A., Blackwell L., Cairns H.S., Carr S., Collins R., Kourellias K., Rogerson M., Scoble J.E., Tomson C.R., Warwick G., Wheeler D.C. The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD. Am. J. Kidney Dis. 2006, 47:385-395.
88. Lee W.N., Bassilian S., Ajie H.O., Schoeller D.A., Edmond J., Bergner E.A., Byerley L.O. In vivo measurement of fatty acids and cholesterol synthesis using D2O and mass isotopomer analysis. Am. J. Physiol. 1994, 266:E699-708.
89. Lee R.G., Willingham M.C., Davis M.A., Skinner K.A., Rudel L.L. Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney, and adrenal of nonhuman primates. J. Lipid Res. 2000, 41:1991-2001.
90. Lin X., Racette S.B., Lefevre M., Ma L., Spearie C.A., Steger-May K., Ostlund R.E. Combined effects of ezetimibe and phytosterols on cholesterol metabolism: a randomized, controlled feeding study in humans. Circulation 2011, 124:596-601.
91. Liu J., Sempos C.T., Donahue R.P., Dorn J., Trevisan M., Grundy S.M. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am. J. Cardiol. 2006, 98:1363-1368.
92. Lutjohann D., Meese C.O., Crouse J.R., von Bergmann K. Evaluation of deuterated cholesterol and deuterated sitostanol for measurement of cholesterol absorption in humans. J. Lipid Res. 1993, 34:1039-1046.
93. Ma P.T., Gil G., Sudhof T.C., Bilheimer D.W., Goldstein J.L., Brown M.S. Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits. Proc. Natl. Acad. Sci. USA 1986, 83:8370-8374.
94. Marangoni F., Poli A. Phytosterols and cardiovascular health. Pharmacol. Res. 2010, 61:193-199.
95. Mastaglia F.L. Iatrogenic myopathies. Curr. Opin. Neurol. 2010, 23:445-449.
96. Matthan N.R., Lichtenstein A.H. Approaches to measuring cholesterol absorption in humans. Atherosclerosis 2004, 174:197-205.
97. Maxfield F.R., Tabas I. Role of cholesterol and lipid organization in disease. Nature 2005, 438:612-621.
98. Mazier M.J., Jones P.J. Diet fat saturation and feeding state modulate rates of cholesterol synthesis in normolipidemic men. J. Nutr. 1997, 127:332-340.
99. McNamara D.J., Proia A., Edwards K.D. Cholesterol homeotasis in rats fed a purified diet. Biochim. Biophys. Acta 1982, 711:252-260.
100. Miettinen T.A., Gylling H. Ineffective decrease of serum cholesterol by simvastatin in a subgroup of hypercholesterolemic coronary patients. Atherosclerosis 2002, 164:147-152.
101. Miettinen T.A., Gylling H., Nissinen M.J. The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption. Nutr. Metab. Cardiovasc. Dis. 2011, 21:765-769.
102. Migdalis I., Efthimiadis A., Pappas S., Alexopoulos D., Vlasserou F., Mikhailidis D.P. Clinical experience with ezetimibe/simvastatin in a Mediterranean population. Curr. Med. Res. Opin. 2009, 25:2571-2576.
103. Mikhailidis D.P., Lawson R.W., McCormick A.L., Sibbring G.C., Tershakovec A.M., Davies G.M., Tunceli K. Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: systematic review and meta-analysis. Curr. Med. Res. Opin. 2011, 27:1191-1210.
104. Mullen P.J., Luscher B., Scharnagl H., Krahenbuhl S., Brecht K. Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells, and consequences for statin-induced myopathy. Biochem. Pharmacol. 2010, 79:1200-1209.
105. Narushima K., Takada T., Yamanashi Y., Suzuki H. Niemann-pick C1-like 1 mediates alpha-tocopherol transport. Mol. Pharmacol. 2008, 74:42-49.
106. Nauli A.M., Nassir F., Zheng S., Yang Q., Lo C.M., Vonlehmden S.B., Lee D., Jandacek R.J., Abumrad N.A., Tso P. CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine. Gastroenterology 2006, 131:1197-1207.
107. Neese R.A., Faix D., Kletke C., Wu K., Wang A.C., Shackleton C.H., Hellerstein M.K. Measurement of endogenous synthesis of plasma cholesterol in rats and humans using MIDA. Am. J. Physiol. 1993, 264:E136-47.
108. Neuvonen P.J., Backman J.T., Niemi M. Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin. Clin. Pharmacokinet. 2008, 47:463-474.
109. Nguyen D.V., Drover V.A., Knopfel M., Dhanasekaran P., Hauser H., Phillips M.C. Influence of class B scavenger receptors on cholesterol flux across the brush border membrane and intestinal absorption. J. Lipid Res. 2009, 50:2235-2244.
110. Niesor E.J. Different effects of compounds decreasing cholesteryl ester transfer protein activity on lipoprotein metabolism. Curr. Opin. Lipidol. 2011, 22:288-295.
111. Nissinen M.J., Gylling H., Miettinen T.A. Responses of surrogate markers of cholesterol absorption and synthesis to changes in cholesterol metabolism during various amounts of fat and cholesterol feeding among healthy men. Br. J. Nutr. 2008, 99:370-378.
112. Nissinen M.J., Miettinen T.E., Gylling H., Miettinen T.A. Applicability of non-cholesterol sterols in predicting response in cholesterol metabolism to simvastatin and fluvastatin treatment among hypercholesterolemic men. Nutr. Metab. Cardiovasc. Dis. 2010, 20:308-316.
113. Osono Y., Woollett L.A., Herz J., Dietschy J.M. Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse. J. Clin. Invest. 1995, 95:1124-1132.
114. Osono Y., Woollett L.A., Marotti K.R., Melchior G.W., Dietschy J.M. Centripetal cholesterol flux from extrahepatic organs to the liver is independent of the concentration of high density lipoprotein-cholesterol in plasma. Proc. Natl. Acad. Sci. USA 1996, 93:4114-4119.
115. Ostlund R.E., McGill J.B., Zeng C.M., Covey D.F., Stearns J., Stenson W.F., Spilburg C.A. Gastrointestinal absorption and plasma kinetics of soy Delta(5)-phytosterols and phytostanols in humans. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E911-6.
116. Oude Elferink R.P., Ottenhoff R., van Wijland M., Smit J.J., Schinkel A.H., Groen A.K. Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. J. Clin. Invest. 1995, 95:31-38.
117. Parker R.A., Clark R.W., Sit S.Y., Lanier T.L., Grosso R.A., Wright J.J. Selective inhibition of cholesterol synthesis in liver versus extrahepatic tissues by HMG-CoA reductase inhibitors. J. Lipid Res. 1990, 31:1271-1282.
118. Plosch T., Bloks V.W., Terasawa Y., Berdy S., Siegler K., Van Der Sluijs F., Kema I.P., Groen A.K., Shan B., Kuipers F., Schwarz M. Sitosterolemia in ABC-transporter G5-deficient mice is aggravated on activation of the liver-X receptor. Gastroenterology 2004, 126:290-300.
119. Plosch T., Kruit J.K., Bloks V.W., Huijkman N.C., Havinga R., Duchateau G.S., Lin Y., Kuipers F. Reduction of cholesterol absorption by dietary plant sterols and stanols in mice is independent of the Abcg5/8 transporter. J. Nutr. 2006, 136:2135-2140.
120. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., Rubin E.M., Breslow J.L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992, 71:343-353.
121. Renfurm L.N., Bandsma R.H., Verkade H.J., Hulzebos C.V., van Dijk T., Boer T., Stellaard F., Kuipers F., Sauer P.J. Cholesterol synthesis and de novo lipogenesis in premature infants determined by mass isotopomer distribution analysis. Pediatr. Res. 2004, 56:602-607.
122. Repa J.J., Lund E.G., Horton J.D., Leitersdorf E., Russell D.W., Dietschy J.M., Turley S.D. Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. Reversal by cholic acid feeding. J. Biol. Chem. 2000, 275:39685-39692.
123. Rezen T., Rozman D., Pascussi J.M., Monostory K. Interplay between cholesterol and drug metabolism. Biochim. Biophys. Acta 2011, 1814:146-160.
124. Richelle M., Enslen M., Hager C., Groux M., Tavazzi I., Godin J.P., Berger A., Metairon S., Quaile S., Piguet-Welsch C., Sagalowicz L., Green H., Fay L.B. Both free and esterified plant sterols reduce cholesterol absorption and the bioavailability of beta-carotene and alpha-tocopherol in normocholesterolemic humans. Am. J. Clin. Nutr. 2004, 80:171-177.
125. Rideout T.C., Harding S.V., Mackay D., Abumweis S.S., Jones P.J. High basal fractional cholesterol synthesis is associated with nonresponse of plasma LDL cholesterol to plant sterol therapy. Am. J. Clin. Nutr. 2010, 92:41-46.
126. Rodwell V.W., Nordstrom J.L., Mitschelen J.J. Regulation of HMG-CoA reductase. Adv. Lipid Res. 1976, 14:1-74.
127. Santosa S., Varady K.A., AbuMweis S., Jones P.J. Physiological and therapeutic factors affecting cholesterol metabolism: does a reciprocal relationship between cholesterol absorption and synthesis really exist?. Life Sci. 2007, 80:505-514.
128. Scandinavian Simvastatin Survival Study Group, 1994. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344, 1383-1389.
129. Scheibner J., Lange K., Empen K., Stange E.F. The contribution of newly synthesized cholesterol to biliary cholesterol in healthy humans. Z. Ernahrungswiss. 1997, 36:368-371.
130. Scholle J.M., Baker W.L., Talati R., Coleman C.I. The effect of adding plant sterols or stanols to statin therapy in hypercholesterolemic patients: systematic review and meta-analysis. J. Am. Coll. Nutr. 2009, 28:517-524.
131. Schwartz C.C., VandenBroek J.M., Cooper P.S. Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans. J. Lipid Res. 2004, 45:1594-1607.
132. Schwarz M., Russell D.W., Dietschy J.M., Turley S.D. Marked reduction in bile acid synthesis in cholesterol 7alpha-hydroxylase-deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia. J. Lipid Res. 1998, 39:1833-1843.
133. Simmonds W.J., Hofmann A.F., Theodor E. Absorption of cholesterol from a micellar solution: intestinal perfusion studies in man. J. Clin. Invest. 1967, 46:874-890.
134. Simonen P., Gylling H., Miettinen T.A. The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes. Atherosclerosis 2008, 197:883-888.
135. Spady D.K., Dietschy J.M. Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat. J. Lipid Res. 1983, 24:303-315.
136. Stange E.F., Dietschy J.M. The origin of cholesterol in the mesenteric lymph of the rat. J. Lipid Res. 1985, 26:175-184.
137. Sudhop T., Lutjohann D., Kodal A., Igel M., Tribble D.L., Shah S., Perevozskaya I., von Bergmann K. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 2002, 106:1943-1948.
138. Sudhop T., Reber M., Tribble D., Sapre A., Taggart W., Gibbons P., Musliner T., von Bergmann K., Lutjohann D. Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in men. J. Lipid Res. 2009, 50:2117-2123.
139. Sweeney M.E., Johnson R.R. Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials. Expert Opin. Drug Metab. Toxicol. 2007, 3:441-450.
140. Talati R., Sobieraj D.M., Makanji S.S., Phung O.J., Coleman C.I. The comparative efficacy of plant sterols and stanols on serum lipids: a systematic review and meta-analysis. J. Am. Diet. Assoc. 2010, 110:719-726.
141. Tang W., Ma Y., Jia L., Ioannou Y.A., Davies J.P., Yu L. Genetic inactivation of NPC1L1 protects against sitosterolemia in mice lacking ABCG5/ABCG8. J. Lipid Res. 2009, 50:293-300.
142. Tang W., Jia L., Ma Y., Xie P., Haywood J., Dawson P.A., Li J., Yu L. Ezetimibe restores biliary cholesterol excretion in mice expressing Niemann-Pick C1-Like 1 only in liver. Biochim. Biophys. Acta 2011, 1811:549-555.
143. Tanigawa H., Billheimer J.T., Tohyama J., Zhang Y., Rothblat G., Rader D.J. Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport. Circulation 2007, 116:1267-1273.
144. Temel R.E., Brown J.M. A new framework for reverse cholesterol transport: non-biliary contributions to reverse cholesterol transport. World J. Gastroenterol. 2010, 16:5946-5952.
145. Temel R.E., Gebre A.K., Parks J.S., Rudel L.L. Compared with Acyl-CoA:cholesterol O-acyltransferase (ACAT) 1 and lecithin:cholesterol acyltransferase, ACAT2 displays the greatest capacity to differentiate cholesterol from sitosterol. J. Biol. Chem. 2003, 278:47594-47601.
146. Temel R.E., Tang W., Ma Y., Rudel L.L., Willingham M.C., Ioannou Y.A., Davies J.P., Nilsson L.M., Yu L. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J. Clin. Invest. 2007, 117:1968-1978.
147. Temel R.E., Sawyer J.K., Yu L., Lord C., Degirolamo C., McDaniel A., Marshall S., Wang N., Shah R., Rudel L.L., Brown J.M. Biliary sterol secretion is not required for macrophage reverse cholesterol transport. Cell Metab. 2010, 12:96-102.
148. Tiemann C.A., Vanlier J., Hilbers P.A., van Riel N.A. Parameter adaptations during phenotype transitions in progressive diseases. BMC Syst. Biol. 2011, 5:174.
149. Tilvis R.S., Miettinen T.A. Serum plant sterols and their relation to cholesterol absorption. Am. J. Clin. Nutr. 1986, 43:92-97.
150. Tsujita Y., Kuroda M., Shimada Y., Tanzawa K., Arai M., Kaneko I., Tanaka M., Masuda H., Tarumi C., Watanabe Y. CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species. Biochim. Biophys. Acta 1986, 877:50-60.
151. Tulenko T.N., Sumner A.E. The physiology of lipoproteins. J. Nucl. Cardiol. 2002, 9:638-649.
152. Turley S.D., Andersen J.M., Dietschy J.M. Rates of sterol synthesis and uptake in the major organs of the rat in vivo. J. Lipid Res. 1981, 22:551-569.
153. Valasek M.A., Weng J., Shaul P.W., Anderson R.G., Repa J.J. Caveolin-1 is not required for murine intestinal cholesterol transport. J. Biol. Chem. 2005, 280:28103-28109.
154. van de Pas N.C., Soffers A.E., Freidig A.P., van Ommen B., Woutersen R.A., Rietjens I.M., de Graaf A.A. Systematic construction of a conceptual minimal model of plasma cholesterol levels based on knockout mouse phenotypes. Biochim. Biophys. Acta 2010, 1801:646-654.
155. van de Pas N.C., Woutersen R.A., van Ommen B., Rietjens I.M., de Graaf A.A. A physiologically-based kinetic model for the prediction of plasma cholesterol concentrations in the mouse. Biochim. Biophys. Acta 2011, 1811:333-342.
156. van den Maagdenberg A.M., Hofker M.H., Krimpenfort P.J., de Bruijn I., van Vlijmen B., van der Boom H., Havekes L.M., Frants R.R. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J. Biol. Chem. 1993, 268:10540-10545.
157. van der Veen J.N., van Dijk T.H., Vrins C.L., van Meer H., Havinga R., Bijsterveld K., Tietge U.J., Groen A.K., Kuipers F. Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol. J. Biol. Chem. 2009, 284:19211-19219.
158. van der Velde A.E., Vrins C.L., van den Oever K., Kunne C., Oude Elferink R.P., Kuipers F., Groen A.K. Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice. Gastroenterology 2007, 133:967-975.
159. van der Velde A.E., Vrins C.L., van den Oever K., Seemann I., Oude Elferink R.P., van Eck M., Kuipers F., Groen A.K. Regulation of direct transintestinal cholesterol excretion in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295:G203-G208.
160. van der Velde A.E., Brufau G., Groen A.K. Transintestinal cholesterol efflux. Curr. Opin. Lipidol. 2010, 21:167-171.
161. van Heek M., Farley C., Compton D.S., Hoos L., Davis H.R. Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function. Br. J. Pharmacol. 2001, 134:409-417.
162. van Schalkwijk D.B., de Graaf A.A., van Ommen B., van Bochove K., Rensen P.C., Havekes L.M., van de Pas N.C., Hoefsloot H.C., van der Greef J., Freidig A.P. Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size. J. Lipid Res. 2009, 50:2398-2411.
163. Vergeer M., Korporaal S.J., Franssen R., Meurs I., Out R., Hovingh G.K., Hoekstra M., Sierts J.A., Dallinga-Thie G.M., Motazacker M.M., Holleboom A.G., Van Berkel T.J., Kastelein J.J., Van Eck M., Kuivenhoven J.A. Genetic variant of the scavenger receptor BI in humans. N. Engl. J. Med. 2011, 364:136-145.
164. Vrins C.L. From blood to gut: direct secretion of cholesterol via transintestinal cholesterol efflux. World J. Gastroenterol. 2010, 16:5953-5957.
165. Vrins C.L., van der Velde A.E., van den Oever K., Levels J.H., Huet S., Oude Elferink R.P., Kuipers F., Groen A.K. Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux. J. Lipid Res. 2009, 50:2046-2054.
166. Wang D.Q., Carey M.C. Measurement of intestinal cholesterol absorption by plasma and fecal dual-isotope ratio, mass balance, and lymph fistula methods in the mouse: an analysis of direct versus indirect methodologies. J. Lipid Res. 2003, 44:1042-1059.
167. Wang J., Sun F., Zhang D.W., Ma Y., Xu F., Belani J.D., Cohen J.C., Hobbs H.H., Xie X.S. Sterol transfer by ABCG5 and ABCG8: in vitro assay and reconstitution. J. Biol. Chem. 2006, 281:27894-27904.
168. Wang H.H., Portincasa P., Mendez-Sanchez N., Uribe M., Wang D.Q. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones. Gastroenterology 2008, 134:2101-2110.
169. Wasko B.M., Smits J.P., Shull L.W., Wiemer D.F., Hohl R.J. A novel bisphosphonate inhibitor of squalene synthase combined with a statin or a nitrogenous bisphosphonate in vitro 2011, J. Lipid Res.
170. West A.M., Anderson J.D., Meyer C.H., Epstein F.H., Wang H., Hagspiel K.D., Berr S.S., Harthun N.L., DiMaria J.M., Hunter J.R., Christopher J.M., Chew J.D., Winberry G.B., Kramer C.M. The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline. Atherosclerosis 2011, 218:156-162.
171. Wetterau J.R., Gregg R.E., Harrity T.W., Arbeeny C., Cap M., Connolly F., Chu C.H., George R.J., Gordon D.A., Jamil H., Jolibois K.G., Kunselman L.K., Lan S.J., Maccagnan T.J., Ricci B., Yan M., Young D., Chen Y., Fryszman O.M., Logan J.V., Musial C.L., Poss M.A., Robl J.A., Simpkins L.M., Slusarchyk W.A., Sulsky R., Taunk P., Magnin D.R., Tino J.A., Lawrence R.M., Dickson J.K., Biller S.A. An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. Science 1998, 282:751-754.
172. Wilson M.D., Rudel L.L. Review of cholesterol absorption with emphasis on dietary and biliary cholesterol. J. Lipid Res. 1994, 35:943-955.
173. Wong W.W., Hachey D.L., Insull W., Opekun A.R., Klein P.D. Effect of dietary cholesterol on cholesterol synthesis in breast-fed and formula-fed infants. J. Lipid Res. 1993, 34:1403-1411.
174. Woollett L.A., Spady D.K., Dietschy J.M. Mechanisms by which saturated triacylglycerols elevate the plasma low density lipoprotein-cholesterol concentration in hamsters. Differential effects of fatty acid chain length. J. Clin. Invest. 1989, 84:119-128.
175. Woollett L.A., Osono Y., Herz J., Dietschy J.M. Apolipoprotein E competitively inhibits receptor-dependent low density lipoprotein uptake by the liver but has no effect on cholesterol absorption or synthesis in the mouse. Proc. Natl. Acad. Sci. USA 1995, 92:12500-12504.
176. Woollett L.A., Wang Y., Buckley D.D., Yao L., Chin S., Granholm N., Jones P.J., Setchell K.D., Tso P., Heubi J.E. Micellar solubilisation of cholesterol is essential for absorption in humans. Gut 2006, 55:197-204.
177. Xie C., Turley S.D., Dietschy J.M. Cholesterol accumulation in tissues of the Niemann-pick type C mouse is determined by the rate of lipoprotein-cholesterol uptake through the coated-pit pathway in each organ. Proc. Natl. Acad. Sci. USA 1999, 96:11992-11997.
178. Xie C., Turley S.D., Dietschy J.M. Centripetal cholesterol flow from the extrahepatic organs through the liver is normal in mice with mutated Niemann-Pick type C protein (NPC1). J. Lipid Res. 2000, 41:1278-1289.
179. Xie C., Woollett L.A., Turley S.D., Dietschy J.M. Fatty acids differentially regulate hepatic cholesteryl ester formation and incorporation into lipoproteins in the liver of the mouse. J. Lipid Res. 2002, 43:1508-1519.
180. Yamanashi Y., Takada T., Yoshikado T., Shoda J., Suzuki H. NPC2 regulates biliary cholesterol secretion via stimulation of ABCG5/G8-mediated cholesterol transport. Gastroenterology 2011, 140:1664-1674.
181. Yount N.Y., Carr T.P., McNamara D.J., Lei K.Y. Incorporation of tritiated water into sterol in copper-deficient rats. Biochim. Biophys. Acta 1991, 1082:79-84.
182. Yu L., Hammer R.E., Li-Hawkins J., Von Bergmann K., Lutjohann D., Cohen J.C., Hobbs H.H. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc. Natl. Acad. Sci. USA 2002, 99:16237-16242.
183. Yu L., Li-Hawkins J., Hammer R.E., Berge K.E., Horton J.D., Cohen J.C., Hobbs H.H. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J. Clin. Invest. 2002, 110:671-680.
184. Yu L., Bharadwaj S., Brown J.M., Ma Y., Du W., Davis M.A., Michaely P., Liu P., Willingham M.C., Rudel L.L. Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake. J. Biol. Chem. 2006, 281:6616-6624.
185. Yunoki K., Nakamura K., Miyoshi T., Enko K., Kohno K., Morita H., Kusano K.F., Ito H. Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction. Atherosclerosis 2011, 217:486-491.